Seeing Is Believing
Currently out of the existing stock ratings of Raghuram Selvaraju, 791 are a BUY (93.72%), 50 are a HOLD (5.92%), 3 are a SELL (0.36%).
Analyst Raghuram Selvaraju, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 28.57% that have a potential upside of 42.42% achieved within 152 days.
Raghuram Selvaraju’s has documented 1,584 price targets and ratings displayed on 96 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on GMAB, Genmab AS at 13-Sep-2024.
Analyst best performing recommendations are on EVOK (EVOKE PHARMA).
The best stock recommendation documented was for EVOK (EVOKE PHARMA) at 7/18/2016. The price target of $288 was fulfilled within 3 days with a profit of $128.16 (30.8%) receiving and performance score of 102.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
9 months 25 days ago
1/3 (33.33%)
$-0.04 (-0.99%)
300
Hold
$1
$-0.07 (-6.54%)
$5
10 months 20 days ago
4/21 (19.05%)
$0.29 (40.85%)
32
Sell
$1
$-0.07 (-6.54%)
$3.5
1 years 1 months 26 days ago
8/11 (72.73%)
$-0.08 (-7.41%)
55
Hold
$1.25
$0.18 (16.82%)
$2
1 years 1 months 26 days ago
2/5 (40%)
$0.17 (15.74%)
215
Buy
$10
2 years 2 months 23 days ago
13/47 (27.66%)
$6.81 (213.48%)
194
Which stock is Raghuram Selvaraju is most bullish on?
Which stock is Raghuram Selvaraju is most reserved on?
What Year was the first public recommendation made by Raghuram Selvaraju?